Global Antifungal Drugs Market is estimated to increase at a CAGR of 3.68% per year- Market Data Forecast

To start with, the global antifungal drug market size is estimated to go from $12.15 billion in 2016 to $14.56 billion in the year 2021, growing with an overall CAGR of 3.68%. Those numbers in itself speaks volumes about the increase in demand for the antifungal drugs in the global market. Now when it comes to India we could only see these numbers growing enormously over the next decade.

Delving into the Indian antifungal drug market, unquestionably the ever increasing Indian population is one major cause for the rise in demand for the antifungal drugs (or for that sake any other drug) in the market. Curious? Well, if the whole of India’s population be divided, then we can vastly put them in two categories – one, those who care least about hygiene and two, those who are obsessed about hygiene. Now the ones who fall under category two, which is a major chunk of them, are the ones that contribute to the rise in demand for the antifungal drugs. As long as these two categories of people exist in the society there will be no dearth in demand for the product.

Some other reasons driving the antifungal drug market size include:

  • Rising awareness amongst people about the antifungal drugs
  • Technology advancement in the antifungal infection therapeutics
  • From business perspective, the growth in investment opportunities

Fungal diseases weren’t deemed as fatal in the 18th and early 19th century. Unlike bacterial, viral or parasitic infections that were considered to be life threatening, fungal infections weren’t recognized as such. However after the antibiotics were discovered, various disease symptoms and unusual microbial colonization were observed by the clinicians during the antibiotic therapy and this led to a probability of fungal organisms being a cause for various diseases, both moderate and fatal, in a human body. It was further studied that the immune state of the individual and the site of infection played a major role in determining the severity of the infection caused by these organisms.

Moderate fungal infections includes Cutaneous Infections like:

  • Fungal nail infection
  • Athlete’s foot
  • Ringworm
  • Vaginal thrush
  • Others

These can be treated using over the counter antifungal drugs, that helps in healing the infection by killing the infected cells and preventing them from growing again.

Some fungal infections that are deemed to be fatal are the mucosal and the systematic infections. They are considered to be an “Opportunistic” as they tend to infect individuals who comprise on their immunity status. These infections are mostly manifested in those suffering from HIV, cystic fibrosis, diabetes, cancer and others

The antifungal drugs are categorized into three major segments,

Topical drugs – As the name suggests they are applied externally on the skin, nail, hair and other infected area.

Oral antifungal drugs – Consumed in the form of tablet, capsule or other. These should be taken under the guidance of the physician as the prescription may vary on the kind and severity of the fungal infection.

Intravenous antifungal drug: These drugs are injected into the veins of the patient directly for the prevention of fungal infection from growing.

Segmentation based on drug type, the antifungal drug market is categorized into

  • Polyenes
  • Azoles
  • Echinocandins
  • allylamines
  • other

Based on the antifungal infection therapeutics the market is categorized into

  • Dermatophytosis
  • Aspergillosis
  • Candidiasis
  • Other antifungal therapeutic indications

Depending on Application the market is segmented by

  • Powders
  • Pastes
  • Drugs
  • Ointments
  • Other applications

Based on the type of Product, the market is categorized into

  • Tablets
  • Injections
  • Capsules
  • Liquids
  • Shampoo
  • Antifungal sprays
  • Gels
  • Cream

Based on the channel of Distribution the antifungal drug market is divided into

  • Hospital pharmacies
  • Retail Pharmacies
  • E-commerce _ Online dealings
  • Specialty Clinics
  • Other

One of the most common challenges experienced by the antifungal drug market today is to manufacture productive drugs in a cost-efficient way. Yet with the necessary technological advancements in the antifungal infection therapeutics, these challenges are countered at a rapid speed, thus allowing the market size to poise to greater heights in the near future.

Check out Market Data Forecast’s comprehensive reports with in-depth analysis about the Antifungal Drugs Market a free research sample can also be availed. Stay tuned for trending news stories about the latest technologies and interesting Healthcare tit-bits.

Share this post:

Recent Posts

Leave a Comment

+ 65 = 74